Skip to main navigation
AvidXchange logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Corporate Governance
    • Our Environmental, Social, Governance (ESG) commitment
    • Governance Overview
    • Leadership
    • Committee Composition
    • Board Diversity Matrix
  • Financial Info
    • SEC Filings
    • Earnings
  • Shareholder Services
    • Investor FAQs
    • Contact Us

Investor Relations

Corporate Profile

An RNA platform to help feed the world and keep it healthy.
Environmental, Social, Governance (ESG) responsibilities are core to this purpose.

 

Latest news releases

Featured Releases

02.01.23
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
01.09.23
GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
11.09.22
GreenLight Biosciences Announces Third Quarter 2022 Financial Results and Highlights Recent Company Progress
  • View All News
Latest events

Presentations

Investor presentation November 2022
Presentation to the Credit Suisse 31st Annual Healthcare Conference - November 7th 2022
Investor presentation - August 10th 2022
  • View All Presentations
Latest earnings

SEC Filings

Filing date Form
09.18.20 DRS
10.15.20 UPLOAD
12.21.20 S-1
  • View All Filings

 

To stay updated with GreenLight news

Sign Up

Shareholder Tools

What we do

  • Platform
  • Human Health
  • Plant and Animal Health

Quick links

  • Careers
  • Contact
  • Partners
  • Press kit

Join us on Social

  • LinkedIn
  • Twitter

Footer Bottom

  • Privacy Policy
  • All rights reserved. 2023 GreenLight Biosciences